JAKi for Atopic Dermatitis Comparable to IL-4, IL-13 Inhibitors in Cancer, Heart Disease Risk
Sizheng Steven Zhao, MBChB, PhD Credit: University of Manchester Individuals with atopic dermatitis who initiate systemic Janus kinase…
Key Risk Factors Uncovered for AD Recurrence After Dupilumab Discontinuation
Patients who discontinue dupilumab treatment after their atopic dermatitis has cleared remain susceptible to relapse and thereby require…